KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) Return on Equity (2016 - 2025)

Historic Return on Equity for Amgen (AMGN) over the last 16 years, with Q4 2025 value amounting to 0.84%.

  • Amgen's Return on Equity rose 2300.0% to 0.84% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.84%, marking a year-over-year increase of 2300.0%. This contributed to the annual value of 1.06% for FY2025, which is 3900.0% up from last year.
  • As of Q4 2025, Amgen's Return on Equity stood at 0.84%, which was up 2300.0% from 0.82% recorded in Q3 2025.
  • Over the past 5 years, Amgen's Return on Equity peaked at 3.94% during Q2 2022, and registered a low of 0.57% during Q2 2024.
  • Over the past 5 years, Amgen's median Return on Equity value was 0.91% (recorded in 2023), while the average stood at 1.18%.
  • Its Return on Equity has fluctuated over the past 5 years, first skyrocketed by 32900bps in 2022, then tumbled by -26300bps in 2023.
  • Over the past 5 years, Amgen's Return on Equity (Quarter) stood at 0.79% in 2021, then soared by 127bps to 1.79% in 2022, then tumbled by -46bps to 0.97% in 2023, then crashed by -37bps to 0.61% in 2024, then surged by 38bps to 0.84% in 2025.
  • Its Return on Equity stands at 0.84% for Q4 2025, versus 0.82% for Q3 2025 and 0.97% for Q2 2025.